ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 234

Population-Based Estimates of Fatigue Prevalence Among Adults Aged >18 Years with and without Arthritis, United States, 2015-2016

Jennifer M. Hootman1, Louise Murphy1, Michael Boring1 and Dana Guglielmo2, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Oak Ridge Institute for Science and Education, Oak Ridge, TN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis and fatigue

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Fatigue is a common symptom among adults with arthritis and can severely impact quality-of life. This study’s two objectives were to estimate the national prevalence of fatigue among US adults with and without arthritis and to describe differences in intensity, duration, sociodemographic and health-related characteristics in fatigue among adults with arthritis.

Methods:

The National Health Interview Survey is an ongoing survey of the civilian, non-institutionalized population designed to gather nationally representative data on a variety of health topics. We analyzed 2015 and 2016 Adult Functioning and Disability Supplement data (sample sizes = 16,939 and 16,478, respectively). Doctor-diagnosed arthritis was defined as a “yes” to: “Have you ever been told by a doctor or other health care professional that you have arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia?” The case finding question for fatigue was “In the past 3 months, how often did you feel very tired or exhausted?” (never, some days, most days, every day). Any fatigue was defined as positive answer some days, most days, or every day. Among those reporting any fatigue, intensity responses were a little, a lot, somewhere in between to “How would you describe the level of tiredness?” and duration responses were some of the day, most of the day, all day to “How long did it last?”. Age-standardized prevalence (%) and 95% confidence intervals (CI) were calculated overall and by sociodemographic characteristics (age, sex, race/ethnicity, and education) and health-related characteristics (arthritis-attributable activity limitation (AAAL), self-rated health (excellent/very good, good, fair/poor), body mass index (BMI) (<25.0, 25.0-<30 and 30.0+), number of co-morbid conditions, and physical activity level (inactive, insufficient, active). Analyses accounted for the complex survey design.

Results:

Any fatigue was higher among adults with arthritis (80.4% CI 78.6–82.0) than without arthritis (60.8% CI 59.8–61.8; p<0.01). Adults with arthritis vs. no arthritis also reported significantly greater “fatigue on most days” (16.4%, CI=14.7-18.3 vs. 7.2%, CI=6.7-7.6) and “fatigue every day” (12.2%, CI=10.7-13.9 vs. 4.1%, CI=3.8-4.5). The highest prevalence of “fatigue every day” among adults with arthritis was observed for those with ≥3 co-morbid conditions (27.4%), reporting fair/poor health (25.9%) and being physically inactive (21.9%). “Fatigue every day” prevalence among adults with arthritis was significantly lower for those age 65+, college degree or higher, no AAAL, no co-morbid conditions, excellent/very good health, and physically active. Among adults with arthritis with any fatigue, 25.8% (CI=23.6-28.1) said their intensity was “a lot”; 24.1% (CI=21.9-26.5) reported a duration of “most of the day” and 12.4% (CI=10.7-14.4) “all of the day”.

Conclusion:

Among adults with arthritis about 4 in 5 report any fatigue, and among those 1 in four report intense (“a lot”) fatigue and 1 in 3 report a duration of most or all of the day. Because pain is an important component of fatigue, exercise and self-management education interventions that lower pain levels may also improve fatigue.


Disclosure: J. M. Hootman, None; L. Murphy, None; M. Boring, None; D. Guglielmo, None.

To cite this abstract in AMA style:

Hootman JM, Murphy L, Boring M, Guglielmo D. Population-Based Estimates of Fatigue Prevalence Among Adults Aged >18 Years with and without Arthritis, United States, 2015-2016 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/population-based-estimates-of-fatigue-prevalence-among-adults-aged-18-years-with-and-without-arthritis-united-states-2015-2016/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/population-based-estimates-of-fatigue-prevalence-among-adults-aged-18-years-with-and-without-arthritis-united-states-2015-2016/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology